Sustainability

Calliditas Therapeutics to Attend Conferences in April

Retrieved on: 
Tuesday, April 9, 2024
Congress, Conference, CALT, Future, Sustainability, LSX, Inflation, Pharma, Person, Pharmaceutical industry

STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that its management will be attending the following upcoming investor and industry conferences:

Key Points: 
  • STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that its management will be attending the following upcoming investor and industry conferences:
    Van Lanschot Kempen Life Sciences Conference Amsterdam, Tuesday, April 16, 2024.
  • Renée Aguiar-Lucander, CEO, will be available for one-on-one meetings.
  • World Orphan Drug Congress, Thursday, April 25, 2024, in Boston, MA.
  • Maria Törnsén, President North America, will be moderating a panel, entitled "Partnering in the rare disease space - industry perspective".

Calliditas Therapeutics to Attend Conferences in April

Retrieved on: 
Tuesday, April 9, 2024
Congress, Conference, CALT, Future, Sustainability, LSX, Inflation, Pharma, Person, Pharmaceutical industry

STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that its management will be attending the following upcoming investor and industry conferences:

Key Points: 
  • STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that its management will be attending the following upcoming investor and industry conferences:
    Van Lanschot Kempen Life Sciences Conference Amsterdam, Tuesday, April 16, 2024.
  • Renée Aguiar-Lucander, CEO, will be available for one-on-one meetings.
  • World Orphan Drug Congress, Thursday, April 25, 2024, in Boston, MA.
  • Maria Törnsén, President North America, will be moderating a panel, entitled "Partnering in the rare disease space - industry perspective".

DEBRAND PARTNERS WITH EASTMAN TO DELIVER CIRCULAR LANYARDS FOR THE 2024 SUSTAINABLE FASHION FORUM

Retrieved on: 
Monday, April 8, 2024
Culture, Recycling, Partnership, Carbon, Sustainability, Renewable energy

VANCOUVER, BC, April 8, 2024 /PRNewswire/ - Next-life logistics solutions provider, Debrand , announced the North American debut of their circular lanyard project with global textile recycler, Eastman , at this year's Sustainable Fashion Forum in Austin, Texas.

Key Points: 
  • VANCOUVER, BC, April 8, 2024 /PRNewswire/ - Next-life logistics solutions provider, Debrand , announced the North American debut of their circular lanyard project with global textile recycler, Eastman , at this year's Sustainable Fashion Forum in Austin, Texas.
  • Debrand will be providing evergreen lanyards designed with circular principles that will be sanitized for reuse at future events.
  • Debrand's circular lanyard project with Eastman exemplifies the kind of innovative, collaborative solutions we strive to showcase," said Brittany Sierra, Founder and CEO of the Sustainable Fashion Forum.
  • "We're thrilled to collaborate with Debrand on this circular lanyard project," said Claudia de Witte, Eastman Textiles Sustainability Leader.

DEBRAND PARTNERS WITH EASTMAN TO DELIVER CIRCULAR LANYARDS FOR THE 2024 SUSTAINABLE FASHION FORUM

Retrieved on: 
Monday, April 8, 2024
Culture, Recycling, Partnership, Carbon, Sustainability, Renewable energy

VANCOUVER, BC, April 8, 2024 /PRNewswire/ -- Next-life logistics solutions provider, Debrand , announced the North American debut of their circular lanyard project with global textile recycler, Eastman , at this year's Sustainable Fashion Forum in Austin, Texas.

Key Points: 
  • VANCOUVER, BC, April 8, 2024 /PRNewswire/ -- Next-life logistics solutions provider, Debrand , announced the North American debut of their circular lanyard project with global textile recycler, Eastman , at this year's Sustainable Fashion Forum in Austin, Texas.
  • Debrand will be providing evergreen lanyards designed with circular principles that will be sanitized for reuse at future events.
  • Debrand's circular lanyard project with Eastman exemplifies the kind of innovative, collaborative solutions we strive to showcase," said Brittany Sierra, Founder and CEO of the Sustainable Fashion Forum.
  • "We're thrilled to collaborate with Debrand on this circular lanyard project," said Claudia de Witte, Eastman Textiles Sustainability Leader.

La Roche-Posay Expands Best-Selling Healing Cicaplast Collection with Cicaplast Gel B5 Skin Protectant and Cicaplast Lips Hydration Restore Lip Balm

Retrieved on: 
Monday, April 8, 2024
Pantothenic acid, SKIN, Panthenol, Face, Hyaluronic acid, Environment, Associate, Patient, Pharmacy, Dermatology, B5, Selenium, MD, Glycerol, Mineral, Skin, LIP, Sustainability, Water, Safety, LIPS, La Roche-Posay, Collection, Lip, Shea butter, Element, Cosmetics

Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.

Key Points: 
  • Created for dry to very dry and sensitive lips, CICAPLAST LIPS HYDRATION RESTORE LIP BALM soothes and softens with a non-greasy texture.
  • Formulated with Vitamin B5 (Panthenol), sustainably sourced Shea Butter and La Roche-Posay Thermal Spring Water, CICAPLAST LIPS HYDRATION RESTORE LIP BALM restores the skin's hydrolipidic film and helps soothe skin.
  • Now, with the launch of CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT, La Roche-Posay is proud to continue to expand its best-selling and healing CICAPLAST collection.
  • CICAPLAST LIPS HYDRATION RESTORE LIP BALM and CICAPLAST GEL B5 SKIN PROTECTANT are:

Microsoft, Junk Kouture, and Best Buy Unite to Foster Eco-Conscious Innovation

Retrieved on: 
Monday, April 8, 2024
Junk Kouture, Microsoft, Microsoft Surface, Recycling, Environment, Electronics, Sustainability, Student, Electronic waste, Imagination, Creativity, Habit, Instinct, Surface Pro 9, Best Buy

NEW YORK, April 8, 2024 /PRNewswire/ -- In an exciting new activation, Microsoft, Junk Kouture, and Best Buy have joined forces in driving eco-conscious habits, responsibly recycling old electronics, and a shared commitment to sustainability. The trio are amplifying and empowering the voices of New York's young creatives, offering them a platform to inspire nationwide recycling efforts, drive change in support of a brighter future, powered by the versatility of the Microsoft Surface Pro 9.

Key Points: 
  • As part of the collaboration, Best Buy—the nation's largest retail collector of e-waste—along with Microsoft and Junk Kouture, is encouraging customers to do their part and make a positive impact on the environment.
  • During Earth Month in April, customers can bring in any eligible laptop or tablet for recycling and save $50 on a Surface device.
  • "Through this innovative moment with Best Buy and Microsoft, we are merging the worlds of fashion, technology, and sustainability.
  • This collaborative effort between Junk Kouture, Best Buy, and Microsoft represents a unique blend of creativity, technology, and environmental consciousness.

LANDSEA HOMES LAUNCHES HIGH PERFORMANCE HOME PROGRAM IN COLORADO; CELEBRATES GRAND OPENINGS FOR TWO NEW COMMUNITIES

Retrieved on: 
Monday, April 8, 2024
Highlands Preserve, Apple, REME, Partnership, Geek Squad, Carbon footprint, Acquisition, Bacteria, Virus, Dander, Dust, House, Thermostat, Pollen, Sustainability, Lighting, LED, Health

*

Key Points: 
  • *
    The company's notable homes merge design, technology, and sustainability to promote energy savings and a healthy lifestyle.
  • Landsea Homes entered the Colorado housing market last October via the acquisition of Richfield Homes.
  • All of Landsea Homes' High Performance Homes are supported by a partnership with Apple®, the homes utilize the Apple HomeKit™ environment to operate all home automation features from one mobile application.
  • For more information about Landsea Homes' High Performance Home program, visit https://landseahomes.com/hph .

Change in Kamux's Group Management Team: Chief Sourcing Officer Juha Saarinen to leave Kamux

Retrieved on: 
Monday, April 8, 2024
Sustainability, EUR, Concept, Nasdaq Helsinki, Management

HÄMEENLINNA, Finland, April 8, 2024 /PRNewswire/ -- Juha Saarinen, Kamux Corporation's Chief Sourcing Officer and a member of the Group Management Team, has decided to leave Kamux in order to pursue a career opportunity outside of Kamux. He will continue in his current position until July 8, 2024. Country organizations will play a stronger role in sourcing and resources for international sourcing will be increased. A recruitment for international sourcing will be started immediately.

Key Points: 
  • HÄMEENLINNA, Finland, April 8, 2024 /PRNewswire/ -- Juha Saarinen, Kamux Corporation's Chief Sourcing Officer and a member of the Group Management Team, has decided to leave Kamux in order to pursue a career opportunity outside of Kamux.
  • Country organizations will play a stronger role in sourcing and resources for international sourcing will be increased.
  • CEO Tapio Pajuharju: "I would like to thank Juha warmly for his contribution as the Chief Sourcing Officer and a member of the Group Management Team at Kamux.
  • The members of the Group Management Team are:
    Aino Hökeberg, Chief Marketing and Concept Officer;
    Marjo Nurmi, Chief People and Sustainability Officer;
    Juha Saarinen, Chief Sourcing Officer (until July 8, 2024); and
    Marjo Nurmi, Chief People and Sustainability Officer, tel.

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Retrieved on: 
Monday, April 8, 2024
Patent, Immunotherapy, CALT, Treatment, Person, Sustainability, PD-1, Pharmaceutical industry

STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no.

Key Points: 
  • STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no.
  • 16/760,910 entitled "Use of NOX Inhibitors for Treatment of Cancer".
  • This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.
  • Calliditas has corresponding applications in several additional territories around the world, including a pending patent application in Europe.

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Retrieved on: 
Monday, April 8, 2024
Patent, Immunotherapy, CALT, Treatment, Person, Sustainability, PD-1, Pharmaceutical industry

STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no.

Key Points: 
  • STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no.
  • 16/760,910 entitled "Use of NOX Inhibitors for Treatment of Cancer".
  • This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.
  • Calliditas has corresponding applications in several additional territories around the world, including a pending patent application in Europe.